These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12991)

  • 1. Evidence in favour of the existence of a dopamine-free prolactin-inhibiting factor (PIF) in rat hypothalamic extracts.
    Enjalbert A; Priam M; Kordon C
    Eur J Pharmacol; 1977 Jan; 41(2):243-4. PubMed ID: 12991
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin release inhibiting and stimulating factors in the hypothalamus.
    Arimura A; Schally AV
    Adv Exp Med Biol; 1977; 87():237-52. PubMed ID: 19952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine, PIF, and other regulators of prolactin secretion.
    Clemens JA; Shaar CJ; Smalstig EB
    Fed Proc; 1980 Sep; 39(11):2907-11. PubMed ID: 6105975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and pituitary prolactin release.
    Ben-Jonathan N
    J Reprod Fertil; 1980 Mar; 58(2):501-12. PubMed ID: 6107382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dopamine, GABA-PIF and in vitro regulation of prolactin secretion in the rat (proceedings) (author's transl)].
    Enjalbert A; Ruberg M; Fiore L; Kordon C
    Ann Endocrinol (Paris); 1978; 39(3):237-8. PubMed ID: 31131
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothalamic control of prolactin and growth hormone secretion in the pituitary gland of the pigeon and the chicken: in vitro studies.
    Hall TR; Chadwick A
    Gen Comp Endocrinol; 1983 Jan; 49(1):135-43. PubMed ID: 6826047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin inhibiting activity of dopamine-free subcellular fractions from rat mediobasal hypothalamus.
    Enjalbert A; Moos F; Carbonell L; Priam M; Kordon C
    Neuroendocrinology; 1977; 24(3-4):147-61. PubMed ID: 24815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of domperidone in the regulation of prolactin release in rats.
    Kato H; Fujino T; Aramaki S; Koresawa M; Yamashita S; Torigoe T
    Life Sci; 1980 Apr; 26(16):1343-7. PubMed ID: 7382720
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothalamic control of prolactin secretion.
    Wuttke W
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S75-6. PubMed ID: 16228
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroendocrine control of prolactin in experimental animals.
    Meites J
    Clin Endocrinol (Oxf); 1977; 6 Suppl():9S-18S. PubMed ID: 30556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the presence of a nondopaminergic, peptidergic prolactin release-inhibiting factor in hypothalamic extracts of infantile rats.
    Khorram O; McCann SM
    Neuroendocrinology; 1986; 44(1):65-9. PubMed ID: 2878386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships between hypothalamic PIF and prolactin release by rat pituitary tissue in vitro.
    Kragt CL; Meites J
    Endocrinology; 1967 Jun; 80(6):1170-3. PubMed ID: 6026090
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothalamic control of prolactin and growth hormone secretion in different vertebrate species.
    Hall TR; Chadwick A
    Gen Comp Endocrinol; 1979 Mar; 37(3):333-42. PubMed ID: 456871
    [No Abstract]   [Full Text] [Related]  

  • 14. Reexamination of dopamine as the prolactin-release inhibiting factor (PIF): supplementary agent may be required for dopamine to function as the physiological PIF.
    Shin SH; Hanna SF; Hong M; Jhamandas K
    Can J Physiol Pharmacol; 1990 Sep; 68(9):1226-30. PubMed ID: 1980429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by dopamine antagonists of DNA synthesis in the pituitary gland of the male rat.
    Jacobi JM; Lloyd HM
    Neuroendocrinology; 1981 Aug; 33(2):97-100. PubMed ID: 7266775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine control of prolactin secretion.
    Leong DA; Frawley LS; Neill JD
    Annu Rev Physiol; 1983; 45():109-27. PubMed ID: 6133499
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of prolactin secretion by the hypothalamic catecholamines.
    MacLeod RM; Login I
    Adv Sex Horm Res; 1976; 2():211-31. PubMed ID: 13627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.
    Takahara J; Arimura A; Schally AV
    Endocrinology; 1974 Aug; 95(2):462-5. PubMed ID: 4854533
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of pituitary prolactin secretion by human placental lactogen in rats.
    Nagasawa H; Yanai R; Yamanouchi K
    J Endocrinol; 1976 Oct; 71(1):115-20. PubMed ID: 10338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid potentiates the inhibitory effect of dopamine on prolactin release: a putative supplementary agent for PIF.
    Shin SH; Stirling RG; Hanna S; Lim M; Wilson JX
    Endocrinol Exp; 1990 Mar; 24(1-2):151-8. PubMed ID: 1972918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.